Delivery Order SPE2DB20D3101-SPE2DB24FRRK7

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,961.96, is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $2,278.28 and a completion date of June 18, 2025. This award is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant...
This is a $6,502.68 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. It has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,749.20 contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The order has an ultimate completion date of December 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with...
This is a $27,090.99 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $3,370.87 and runs through May 21, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.74 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $10,512.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to manage diabetes. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside requirements indicated for this award. This order is...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL, a prescription medication used for diabetes management. The contract has a ceiling value of $23,925.36 and a completion date of May 30, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $13,348.47 and a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRRK7
    Delivery Order

This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $24,306.55 and a term ending on August 2, 2024. Amerisourcebergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This award does not have a set-aside designation.

Generated 10/31/24, 9:18 AM